Hydrophosphorylation of hydrazones
Russ.Chem.Bull., Int.Ed., Vol. 59, No. 3, March, 2010
587
3
δ: 1.14, 1.31 (both t, 6 H, 2 Me, POEt, JH,H = 7.1 Hz);
3.75—3.85, 3.94—4.04 (both m, 1 H each, OCH2); 4.11—4.19
(m, 2 H, OCH2); 4.94 (d, 1 H, CH, 2JH,P = 22.5 Hz); 6.28 (br.s,
2 H, NH); 7.23—7.31 (m, 4 H, arom.); 7.37 (t, 2 H, arom.,
3JH,H = 7.5 Hz); 7.47—7.48 (m, 4 H, arom.); 7.65 (s, 1 H,
CH=N). 31P NMR, δ: 22.08. 13C NMR, δ: 16.22, 16.45 (both d,
(s, 1 H, CH=N); 7.76 (d, 1 H, arom., 3JH,H = 5.9 Hz); 7.84 (d, 1 H,
3
3
arom., JH,H = 8.1 Hz); 8.06 (d, 1 H, arom., JH,H = 8.5 Hz);
8.17 (d, 1 H, arom., 3JH,H = 8.3 Hz); 8.26 (s, 1 H, arom.); 8.37
(d, 1 H, arom., 4JH,P = 2.0 Hz). 31P NMR, δ: 19.67. 13C NMR,
3
3
δ: 16.29, 16.43 (both d, Me, POEt, JC,P = 5.1 Hz, JC,P
=
= 5.8 Hz); 60.07 (d, CH, 1JC,P = 148.6 Hz); 63.47, 63.63 (both d,
OCH2, 2JC,P = 6.6 Hz, 2JC,P = 7.3 Hz); 120.69, 122.86, 123.04,
123.11, 129.44, 129.53, 131.55, 134.30 (d, JC,P = 5.1 Hz);
3
3
Me, POEt, JC,P = 5.1 Hz, JC,P = 5.9 Hz); 61.15 (d, CH,
1JC,P = 148.5 Hz); 63.09, 63.15 (both d, OCH2, 2JC,P = 5.9 Hz,
2JC,P = 6.5 Hz); 126.17, 127.96, 128.16, 128.21, 128.43, 128.60,
135.20, 135.52 (Carom); 140.19 (s, CH=N). IR, ν/cm–1: 1030,
1070 (P—O—C); 1250 (P=O); 1600 (CH=N); 3230 (N—H).
Tetraethyl α,α´ꢀhydrazobis(benzylphosphonate) (6), m.p.
3
136.83, 137.46, 138.06, 148.43, 148.53 (Carom); 143.60
(d, CH=N, 4JC,P = 2.9 Hz). IR, ν/cm–1: 1030, 1070 (P—O—C);
1250 (P=O); 1350, 1530 (N=O, NO2); 1600 (CH=N); 3230
(N—H). MS, m/z: 436 [M]+, 299 [M – P(O)(OEt)2]+, 138
[P(OH)(OEt)2]+. Found (%): C, 49.60; H, 5.08; N, 12.61.
C18H21N4O7P. Calculated (%): C, 49.55; H, 4.85; N, 12.84.
Tetraethyl α,α´ꢀhydrazobis(3ꢀnitrobenzylphosphonate) (10),
m.p. 105—108 °C. 1H NMR, δ: 1.04, 1.05, 1.13, 1.18 (all t, 12 H,
Me, POEt, 3JH,H = 7.1 Hz); 3.76—3.93, 3.94—4.11 (both m, 4 H
each, OCH2); 4.28 (br.s, 2 H, NHNH); 5.31, 5.46 (both d, 2 H,
1
92—95 °C. H NMR, δ: 1.01, 1.03, 1.13, 1.19 (all t, 12 H, Me,
POEt, 3JH,H = 7.1 Hz); 3.62—3.72 (m, 2 H, OCH2); 3.80—4.03
(m, 8 H, OCH2, NHNH); 4.13, 4.31 (both d, 2 H, CH, 2JH,P
=
= 20.7 Hz); 7.28—7.42 (m, 10 H, arom.). 31P NMR, δ: 21.22,
21.27. 13C NMR, δ: 16.09—16.36 (m, Me, POEt); 60.51, 63.35
(both d, CH, JC,P = 148.5 Hz, 1JC,P = 147.9 Hz); 62.64, 63.14
1
(both d, OCH2, 2JC,P = 7.3 Hz, 2JC,P = 6.6 Hz); 128.11, 128.55,
128.66, 128.72, 134.40, 135.50 (Carom). IR, ν/cm–1: 1040, 1070
(P—O—C); 1250 (P=O); 3260 (NH). Found (%): C, 54.37;
H, 7.15; N, 5.56. C22H34N2O6P2. Calculated (%): C, 54.54;
H, 7.07; N, 5.78.
CH, JH,P = 22.2 Hz, JH,P = 22.5 Hz); 7.37—7.46 (m, 2 H,
arom.); 7.50—7.54, 7.60—7.64 (both m, 2 H, arom.); 7.70—7.73,
7.79—7.83 (both m, 2 H, arom.); 7.86, 7.88 (both d, 2 H, arom.,
3JH,H = 8.1 Hz). 31P NMR, δ: 19.37, 19.64. 13C NMR, δ: 16.01,
16.19 (both d, Me, POEt, 3JC,P = 5.9 Hz, 3JC,P = 5.1 Hz); 55.89,
2
2
1
Diethyl (2ꢀmethoxyphenyl)(2ꢀmethoxybenzylidenehydrazino)ꢀ
methylphosphonate (7), m.p. 109—110 °C. 1H NMR, δ: 1.09,
1.32 (both t, 6 H, Me, POEt, 3JH,H = 7.1 Hz); 3.70—3.81, 3.84—3.97
(both m, 1 H each, OCH2); 3.78, 3.91 (both s, 3 H each, 2 OMe);
4.16—4.23 (m, 2 H, OCH2); 5.53 (d, 1 H, CH, 2JH,P = 22.0 Hz);
6.80—6.98 (m, 4 H, arom.); 7.18—7.28 (m, 2 H, arom.); 7.46
57.32 (both d, CH, 1JC2,P = 145.7 Hz, JC,P = 146.3 Hz); 62.96,
63.52 (both d, OCH2, JC,P = 7.4 Hz); 124.74, 124.82, 128.46,
3
3
129.53 (d, JC,P = 2.2 Hz); 129.79 (d, JC,P = 2.9 Hz); 130.75,
131.11, 132.90, 133.10, 149.95, 150.02 (Carom). IR, ν/cm–1: 1030,
1060 (P—O—C); 1240 (P=O); 1360, 1525 (N=O); 3270 (N—H).
Found (%): C, 46.18; H, 5.74; N, 9.58. C22H32N4O10P2. Calcuꢀ
lated (%): C, 46.00; H, 5.61; N, 9.75.
3
3
(d, 1 H, arom., JH,H = 7.5 Hz); 7.74 (dd, 1 H, arom., JH,H
=
= 7.7 Hz, 4JH,H = 1.4 Hz); 8.02 (s, 1 H, CH=N). 31P NMR, δ:
Diethyl 1ꢀ(cyclopentylidenehydrazino)cyclopentylphosphonate
22.70. 13C NMR, δ: 16.16, 16.46 (both d, Me, POEt, JC,P
=
(11). H NMR, δ: 1.27 (t, 6 H, 2 Me, POEt, JH,H = 7.0 Hz);
1.62—1.69 (m, 4 H, ring); 1.74—1.81 (m, 4 H, ring); 1.93—2.06
(m, 4 H, ring); 2.12 (t, 2 H, ring, 3JH,H = 7.3 Hz); 2.29 (t, 2 H,
ring, 3JH,H = 7.2 Hz); 4.01—4.09 (m, 4 H, 2 OCH2); 4.71 (br.s,
1 H, NH). 31P NMR, δ: 31.45. 13C NMR, δ: 16.50 (d, Me, POEt,
3
1
3
3
1
= 5.9 Hz, JC,P = 6.6 Hz); 53.74 (d, CH, JC,P = 152.2 Hz);
55.51, 55.75 (both s, 2 OMe); 62.93 (d, OCH2, 2JC,P = 7.4 Hz);
110.76, 110.92, 120.70, 120.89, 123.87, 125.62, 128.56,
128.86, 129.04, 129.28 156.81, 157.24 (d, 3JC,P = 6.5 Hz) (Carom);
135.34 (s, CH=N). IR, ν/cm–1: 1040, 1060 (P—O—C); 1250
(P=O); 1600 (CH=N); 3230 (N—H). Found (%): C, 59.38;
H, 6.68; N, 6.85. C20H27N2O5P. Calculated (%): C, 59.11;
H, 6.70; N, 6.89.
3JC,P = 5.1 Hz); 24.87, 26.27, 33.16, 33.83 (d, JC,P = 5.8 Hz)
(Cring); 61.69 (d, OCH2, JC,P = 7.3 Hz); 66.17 (d, C, JC,P
2
2
1
=
= 147.8 Hz); 158.47 (C=N). IR, ν/cm–1: 1040, 1070 (P—O—C);
1240 (P=O); 1650 (C=N); 3250 (N—H). Found (%): C, 55.73;
H, 9.22; N, 9.17. C14H27N2O3P. Calculated (%): C, 55.61;
H, 9.00; N, 9.27.
Tetraethyl 1,1´ꢀhydrazobis(cyclopentylphosphonate) (12).
1H NMR, δ: 1.26 (t, 6 H, 2 Me, POEt, 3JH,H = 7.0 Hz); 1.58—1.82
(m, 14 H, ring); 2.04—2.14 (m, 1 H, ring); 2.30—2.34 (m, 1 H,
Tetraethyl α,α´ꢀhydrazobis(2ꢀmethoxybenzylphosphonate)
(8), m.p. 44—46 °C. 1H NMR, δ: 1.00—1.05 (m, 6 H, 2 Me,
3
POEt); 1.18, 1.24 (both t, 6 H, 2 Me, POEt, JH,H = 7.1 Hz);
3.66—4.09 (m, 14 H, 4 OCH2, 2 OMe); 4.80, 4.98 (both d, 2 H,
2
2
CH, JH,P = 21.5 Hz, JH,P = 21.3 Hz); 6.82—7.32 (m, 8 H,
arom.). 31P NMR, δ: 22.20, 22.31. 13C NMR, δ: 16.05—16.42
ring); 3.73 (br.s, 2 H, NHNH); 4.03—4.11 (m, 4 H, 2 OCH2).
1
3
(m, Me, POEt); 53.34, 56.06 (both d, CH, JC,P = 150.7 Hz,
31P NMR, δ: 31.88. 13C NMR, δ: 16.53 (d, Me, POEt, JC,P
=
1JC,P = 150 Hz); 55.39, 55.75 (both s, 2 OMe); 62.93
(m, 4 OCH2); 110.53, 110.75, 120.59, 120.90, 123.84, 128.88,
126.99 (Carom); 157.61, 158.00 (both d, COMe, 3JC,P = 7.3 Hz,
3JC,P = 8.1 Hz). IR, ν/cm–1: 1040, 1080 (P—O—C); 1270 (P=O);
3270 (N—H). MS, m/z: 544 [M]+, 407 [M – P(O)(OEt)2]+, 269
[M – 2 P(O)(OEt)2 – H]+, 137 [P(O)(OEt)2]+. Found (%):
C, 53.16; H, 7.20; N, 4.99. C24H38N2O8P2. Calculated (%):
C, 52.94; H, 7.03; N, 5.14.
= 5.0 Hz); 24.46 (d, 2JC,P = 8.1 Hz), 32.72 (d, 3JC,P = 11.7 Hz)
2
1
(Cring); 61.63 (d, OCH2, JC,P = 7.4 Hz); 65.75 (d, C, JC,P
=
= 143.5 Hz). IR, ν/cm–1: 1040, 1060 (P—O—C); 1250 (P=O);
3280 (N—H). MS, m/z: 440 [M]+, 303 [M – P(O)(OEt)2]+,
165 [M – 2P(O)(OEt)2 – H]+, 138 [P(OH)(OEt)2]+. Found (%):
C, 49.22; H, 8.70; N, 6.38. C18H38N2O6P2. Calculated (%):
C, 49.08; H, 8.70; N, 6.36.
Diethyl 1ꢀ(cyclohexylidenehydrazino)cyclohexylphosphonate
(13), m.p. 90—91 °C (cf. Ref. 17: m.p. 87 °C). 1H NMR, δ:
1.15—1.34 (m, 2 H, ring); 1.29 (t, 6 H, 2 Me, POEt, 3JH,H = 7.0 Hz);
1.42—2.07 (m, 16 H, ring); 2.20—2.25 (m, 2 H, ring), 3.98—4.20
(m, 4 H, 2 OCH2). 31P NMR, δ: 31.35. 13C NMR, δ: 16.51
Diethyl (3ꢀnitrobenzylidenehydrazino)(3ꢀnitrophenyl)methylꢀ
phosphonate (9), m.p. 155—156 °C. 1H NMR, δ: 1.23, 1.34 (both t,
6 H, Me, POEt, 3JH,H = 7.1 Hz); 3.94—4.05, 4.05—4.13 (both m,
1 H each, OCH2); 4.15—4.23 (m, 2 H, OCH2); 5.08 (dd, 1 H,
CH, JH,P = 22.0 Hz, JH,H = 6.3 Hz); 7.44 (t, 1 H, arom.,
3JH,H = 8.0 Hz); 7.56 (t, 1 H, arom., JH,H = 8.0 Hz); 7.75
2
3
3
(d, Me, POEt, JC,P = 5.9 Hz); 20.15, 20.26, 24.98, 25.61
3
3
(d, JC,P = 5.8 Hz), 25.89, 26.98, 29.05, 35.42 (Cring); 58.59